Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P347: Evaluation of step up therapy in patients with early ulcerative colitis: a prospective cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Bossuyt P.*1,2, Baert F.3, Coenegrachts J.-L.4, De Vos M.5, Dewit O.6, Ferrante M.7, Fontaine F.8, Mana F.9, Vandervoort J.10, Moreels T.11 Belgian IBD Research and Development Group

1University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium 2Imelda GI Clinical Research Center, Department of Gastroenterology, Bonheiden, Belgium 3AZ Delta, Department of Gastroenterology, Roeselare, Belgium 4Jessa Hospital Hasselt, Department of Gastroenterology, Hasselt, Belgium 5Ghent University Hospital, Gastroenterology, Ghent, Belgium 6UCL Saint-Luc, Department of Gastroenterology, Brussels, Belgium 7UZ Leuven, Campus Gasthuisberg, Department of Gastroenterology and Hepatology, Leuven, Belgium 8CHC Site St. Joseph, Department of Gastroenterology, Liège, Belgium 9UZ Brussels, Department of Gastroenterology, Brussels, Belgium 10OLV Hospital Aalst-Asse-Ninove, Departement Of Gastroenterology, Aalst, Belgium 11University Hospital Antwerp, Department of Gastroenterology and Hepatology, Edegem, Belgium

P348: Persistent hyperCKemia during infliximab therapy in patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Theodoraki E., Orfanoudaki E., Foteinogiannopoulou K., Koutroubakis I.

University Hospital of Heraklion, Greece, Gastroenterology, Heraklion, Crete, Greece, Greece

P349: The therapies influencing postoperative surgical recurrence in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Shinozaki M.

The Institute of Medical Science, The University of Tokyo, Department of Surgery, Tokyo, Japan

P350: Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agentsECCO '17 Barcelona
Year: 2017
Authors:

Robles V., Herrera deGuise C., Guirola M.A., Borruel N., Casellas F.

Unitat d'Atenciό Crohn-Colitis. Hospital Universitari Vall d'Hebron, Digestive Diseases Research, Barcelona, Spain

P351: Do self-selected “Non-Transitioned” referrals from peadiatric services have lower treatment requirements?ECCO '17 Barcelona
Year: 2017
Authors:

Shaikh O.1, Harvey P.*1, Cooney R.1, Muhammed R.2

1University Hospital Birmingham, Gastroenterology, Birmingham, United Kingdom 2Birmingham Children's Hospital NHS Trust, Paediatric Gastroenterology, Birmingham, United Kingdom

P352: Assessment of the use of therapeutic drug monitoring of Adalimumab during maintenance therapy in children with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Chavannes M.*1, Gervais F.1, Verreault A.2, Deslandres C.1, Jantchou P.2

1Sainte Justine University Hospital, Pediatric Gastroenterology, Montreal, Canada 2Sainte Justine University Hospital, Research Center of the CHU Sainte Justine, Montreal, Canada

P353: Long-term safety of adalimumab in patients with Crohn's disease: final data from PYRAMID registryECCO '17 Barcelona
Year: 2017
Authors:

D'Haens G.*1, Reinisch W.2, Satsangi J.3, Loftus Jr. E.V.4, Panaccione R.5, Alperovich G.6, Kalabic J.7, Bereswill M.7, Arikan D.8, Petersson J.8, Robinson A.M.8

1Academic Medical Centre, Department of Gastroenterology, Amsterdam, Netherlands 2Medical University of Vienna, Vienna, Austria 3Western General Hospital, Gastrointestinal Unit, Edinburgh, United Kingdom 4Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, United States 5University of Calgary, Department of Medicine, Calgary, Canada 6AbbVie Spain S.L.U., Madrid, Spain 7AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany 8AbbVie Inc., North Chicago, United States

P354: The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patientsECCO '17 Barcelona
Year: 2017
Authors:

Zand A., Aredas E., Duran N., DiNicola C., Lacey P., Arenas A., Hommes D.W.

UCLA Center for Inflammatory Bowel Diseases, Los Angeles, United States

P355: A structured care pathway improves quality of care for acute severe ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Neary B., Doherty G., Rafter N., Gibson D.

St Vincent's University Hospital, Gastroenterology, Dublin, Ireland

P356: Treatment with anakinra induces T cell production of IL22 and GI mucosal healing in an IL-10RA mutation patientECCO '17 Barcelona
Year: 2017
Authors:

Li J.1, Shouval D.2, Doty A.1, Snapper S.3, Glover S.*1

1University of Florida, Gainesville, United States 2Tel Aviv University, Tel Aviv, Israel 3Harvard University, Boston, United States

P357: A multi-institutional report of postoperative outcomes in Vedolizumab-Treated patients undergoing major abdominal operations for inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Lightner A.*1, Mathis K.2, Sang Tse C.3, Pemberton J.1, Shen B.4, Kocklar G.4, Singh A.4, Parambir D.5, Eisenstein S.6, Stringfield S.5, Hudesman D.7, Remzi F.8, Loftus E.3

1Mayo Clinic, Colon and Rectal Surgery, Rochester, United States 2Mayo Clinic, colon and rectal surgery, Rochester, United States 3Mayo Clinic, Gastroenterology, Rochester, United States 4Cleveland Clinic, Gastroenterology, Cleveland, United States 5University of California at San Diego, Gastroenterology, San Diego, United States 6University of California at San Diego, Colon and Rectal Surgery, San Diego, United States 7New York University, Gastroenterology, New York City, United States 8New York University, Colon and Rectal Surgery, New York City, United States

P358: Efficacy of golimumab for the treatment of ulcerative colitis patients in clinical practice: a retrospective cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Dufour G.*1, Altwegg R.1, Valats J.-C.1, Bismuth M.1, Funakoshi N.1, Gonzalez F.1, Caillo L.2, Pouderoux P.2, Blanc P.1, Pineton de Chambrun G.1

1Montpellier University, Gastroenterology and Hepatology, Montpellier, France 2CHU University Hospital, Department of Hepatology and Gastroenterology, Nîmes, France

P359: Correlation between physician and patient disease assessments in ulcerative colitis: baseline data from the ICONIC study of 1816 patients in 33 countriesECCO '17 Barcelona
Year: 2017
Authors:

Ghosh S.*1, Peyrin-Biroulet L.2, Sensky T.3, Casellas F.4, O'Shea C.5, Pappalardo B.6

1University of Birmingham, Birmingham, Ukraine 2University of Lorraine, Nancy, France 3Imperial College, London, United Kingdom 4Crohn-Colitis Care Unit (UACC), Hospital Universitari Vall d'Hebron, Barcelona, Spain 5AbbVie Ltd, Dublin, Ireland 6AbbVie Inc., North Chicago, IL, United States

P360: Trough levels and antibodies to ustekinumab are not correlated to response to ustekinumab treatment in Crohn's disease patientsECCO '17 Barcelona
Year: 2017
Authors:

Claire P.*1, Severine B.2, Nicolas D.3, Maria N.4, Pierre D.4, Julien B.4, Romain G.4, Medina B.4, Myriam L.2, Benjamin P.4

1Lille 2, Gastrenterology, Lille, France 2Lille 2, Immunology laboratory, Lille, France 3CHU Roubaix, Gastroenterology, Roubaix, France 4Lille 2, Gastroenterology, Lille, France

P361: Machine learning models at week 6 of vedolizumab therapy for ulcerative colitis can predict week 52 corticosteroid free endoscopic remissionECCO '17 Barcelona
Year: 2017
Authors:

Waljee A.1, Liu B.2, Sauder K.1, Zhu J.2, Govani S.1, Stidham R.W.1, Higgins P.D.*3

1University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, United States 2University of Michigan, Statistics, Ann Arbor, United States 3University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, MI, United States

P362: Magnetic resonance healing predicts long-term outcomes in patients with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Raimundo Fernandes S.*1, Correia L.1, Baldaia C.2, Moura Santos P.2, Rita Gonçalves A.2, Valente A.2, Velosa J.1

1Hospital de Santa Maria, Serviço de Gastrenterologia e Hepatologia, Lisboa, Portugal 2Centro Hospitalar Lisboa Norte, Gastrenterology, Lisbon, Portugal

P363: The impact of transition to adult gastroenterology services on health-related quality of life in young adult patients with IBD: the UK TRANSIT studyECCO '17 Barcelona
Year: 2017
Authors:

McCartney S.*1, Lindsay J.2, Russell R.3, Gaya D.3, Shaw I.4, Murray C.5, Finney-Hayward T.6, Sebastian S.7

1University College London Hospitals NHS Foundation Trust, London, United Kingdom 2Barts Health NHS Trust, London, United Kingdom 3NHS Greater Glasgow and Clyde, Glasgow, United Kingdom 4Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom 5Royal Free London NHS Foundation Trust, London, United Kingdom 6AbbVie, Maidenhead, United Kingdom 7Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

P364: A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Eriksson C.1, Rundquist S.*2, Lykiardopoulos B.3, Karlén P.4, Grip O.5, Söderman C.6, Almer S.7, Hertervig E.8, Gunnarsson J.9, Delin J.10, Strid H.11, Sjöberg M.12, Öberg D.13, Hjortswang H.3, Halfvarson J.14 The SWIBREG SVEAH Study Group

1Örebro University Hospital, Department of Gastroenterology, Örebro, Sweden 2Örebro University, Örebro, Sweden 3Linköping University, Department of Gastroenterology, Linköping, Sweden 4Danderyd Hospital, Department of Internal Medicine, Stockholm, Sweden 5Skane University Hospital Malmö, Department of Gastroenterology, Malmö, Sweden 6St Göran hospital, Department of Internal Medicine, Stockholm, Sweden 7Karolinska Institute, Department of Medicine, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden 8Skane University Hospital Lund, Department of Gastroenterology, Lund, Sweden 9Kungsbacka Hospital, Department of Internal Medicine, Kungsbacka, Sweden 10Ersta hospital, Department of Gastroenterology, Stockholm, Sweden 11Södra Älvsborgs Sjukhus, Borås, Department of Internal Medicine, Borås, Sweden 12Skaraborgs hospital Lidköping, Department of Internal Medicine, Lidköping, Sweden 13Sunderby Hospital, Department of Internal Medicine, Sunderbyn, Sweden 14Faculty of Medicine and Health, Örebro University, Örebro, Sweden

P365: Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practiceECCO '17 Barcelona
Year: 2017
Authors:

Aguas M.*1,2, Bosό V.3, Navarro B.1, Marqués-Miñana M.R.3, Bastida G.1,2, Beltrán B.1,2, Iborra M.1,2, Monte-Boquet E.3, Poveda-Andrés J.L.3, Nos P.1,2

1La Fe University and Politechnic Hospital, Gastroenterology, Valencia, Spain 2CIBEREHD, Networked Biomedical Research Center for Hepatic and Digestive Diseases, Valencia, Spain 3La Fe University and Polytechnic Hospital, Pharmacy, Medication Clinical Area, Valencia, Spain

P366: The efficacy of vedolizumab for induction of clinical response and remission in anti-TNF naïve patients with inflammatory bowel disease – a multicenter European real world experienceECCO '17 Barcelona
Year: 2017
Authors:

Kopylov U.*1, Sebastian S.2, Ron Y.3, Steinhagen P.R.4, Roblin X.5, Pugliese D.6, Bar-Gil Shitrit A.7, Katsanos K.8, Fiorino G.9, Allocca M.10, Sipponen T.11, Ungar B.12, Armuzzi A.6, Eliakim R.12, Christodoulou D.8, Baumgart D.C.4, Ben-Horin S.12, Dotan I.3

1Sheba Medical Center, Gastroenterology, Tel Hashomer, Israel 2Hull Royal Infirmary, Hull & East Yorkshire Hospitals NHS Trust, Department of Gastroenterology and Hepatology, Hull, United Kingdom 3Tel Aviv Medical Ceter, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel 4Charité - University Hospital Berlin, Campus Benjamin Franklin, Department of Gastroenterology and Medicine I, Berlin, Germany 5CHU de Saint-Etienne, Gastroenterology, Saint-Etiennne, France 6IBD Unit, Complesso Integrato Columbus, Fondazione Policlinico Gemelli, Università Cattolica, internal Medicine, Gastroenterology Division, Rome, Italy 7Shaare Zedek Medical Center, Digestive diseases Institute, Jerusalem, Israel 8University of Ioannina, Gastroenterology, Ioannina, Greece 9Humanitas Research Hospital, Department of Gastroenterology, IBD Center, Rozzano, Italy 10Humanitas Gradenigo, Gastroenterology, Turin, Italy 11Helsinki University Central Hospital - Meilahti Hospital, Department of Gastroenterology, Helsinki, Finland 12Chaim Sheba Medical Center, Gastroenterology, Ramat Gan, Israel